| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:10:37 -0700 |
| HMDB ID |
HMDB01473 |
| Secondary Accession Numbers |
|
| Metabolite Identification |
| Common Name |
Dihydroxyacetone phosphate |
| Description |
Dihydroxyacetone phosphate is an important intermediate in lipid biosynthesis and in glycolysis. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 1,3-Dihydroxy-2-Propanone mono(dihydrogen phosphate)
- 1,3-Dihydroxy-2-propanone phosphate
- 1,3-Dihydroxyacetone 1-phosphate
- 1-Hydroxy-3-(phosphonooxy)-2-Propanone
- 1-Hydroxy-3-(phosphonooxy)acetone
- DHAP
- Di-OH-acetone-P
- Dihydroxy-Acetone-P
- Dihydroxy-acetone-phosphate
- Dihydroxyacetone 3-phosphate
- Dihydroxyacetone monophosphate
- Dihydroxyacetone phosphate
- Dihydroxyacetone-P
- Dihydroxyacetone-phosphate
- Glycerone phosphate
- Glycerone-phosphate
- Phosphoric acid ester with 1,3-dihydroxy-2-propanone
|
| Chemical Formula |
C3H7O6P |
| Average Molecular Weight |
170.0578 |
| Monoisotopic Molecular Weight |
169.998024468 |
| IUPAC Name |
(3-hydroxy-2-oxopropoxy)phosphonic acid |
| Traditional IUPAC Name |
3-hydroxy-2-oxopropoxyphosphonic acid |
| CAS Registry Number |
57-04-5 |
| SMILES |
OCC(=O)COP(O)(O)=O |
| InChI Identifier |
InChI=1S/C3H7O6P/c4-1-3(5)2-9-10(6,7)8/h4H,1-2H2,(H2,6,7,8) |
| InChI Key |
GNGACRATGGDKBX-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Organophosphorus Compounds |
| Class |
Organic Phosphoric Acids and Derivatives |
| Sub Class |
Organophosphate Esters |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- glycerone phosphates(ChEBI)
|
| Substituents |
- Alpha Ketoaldehyde
- Ketone
- Organic Hypophosphite
- Organic Phosphite
- Primary Alcohol
|
| Direct Parent |
Organophosphate Esters |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Fructose and mannose metabolism
- Component of Glycerophospholipid metabolism
- Component of Inositol metabolism
|
| Application |
Not Available |
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
|
| Tissue Location |
Not Available
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
12.1 +/- 5.1 uM |
Newborn (0-30 days old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
15.6 +/- 4.56 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cellular Cytoplasm |
Detected and Quantified |
|
140 (60-220) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
1.88 +/- 0.34 uM |
Adult (>18 years old) |
Both |
Transaldolase deficiency |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Transaldolase deficiency |
- Huck JH, Struys EA, Verhoeven NM, Jakobs C, van der Knaap MS: Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency. Clin Chem. 2003 Aug;49(8):1375-80.
Pubmed: 12881455
|
|
| Associated OMIM IDs |
- 606003
(Transaldolase deficiency)
|
| External Links |
| DrugBank ID |
DB04326  |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB001618 |
| KNApSAcK ID |
C00007560  |
| Chemspider ID |
648  |
| KEGG Compound ID |
C00111  |
| BioCyc ID |
DIHYDROXY-ACETONE-PHOSPHATE  |
| BiGG ID |
33898  |
| Wikipedia Link |
Dihydroxyacetone phosphate  |
| NuGOwiki Link |
HMDB01473  |
| Metagene Link |
HMDB01473  |
| METLIN ID |
6262  |
| PubChem Compound |
668  |
| PDB ID |
13P  |
| ChEBI ID |
16108  |
| References |
| Synthesis Reference |
Ballou, Clinton E.; Fischer, Hermann O. L. The synthesis of dihydroxyacetone phosphate. Journal of the American Chemical Society (1956), 78 1659-61. |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
- Roberts NB, Dutton J, Helliwell T, Rothwell PJ, Kavanagh JP: Pyrophosphate in synovial fluid and urine and its relationship to urinary risk factors for stone disease. Ann Clin Biochem. 1992 Sep;29 ( Pt 5):529-34.
Pubmed: 1332571
- Yamamoto T, Moriwaki Y, Takahashi S, Ohata H, Nakano T, Yamakita J, Higashino K: Effect of glucagon on the xylitol-induced increase in the plasma concentration and urinary excretion of purine bases. Metabolism. 1996 Nov;45(11):1354-9.
Pubmed: 8931639
- Schutgens RB, Wanders RJ, Heymans HS, Schram AW, Tager JM, Schrakamp G, van den Bosch H: Zellweger syndrome: biochemical procedures in diagnosis, prevention and treatment. J Inherit Metab Dis. 1987;10 Suppl 1:33-45.
Pubmed: 3119940
- Nakayama Y, Kinoshita A, Tomita M: Dynamic simulation of red blood cell metabolism and its application to the analysis of a pathological condition. Theor Biol Med Model. 2005 May 9;2(1):18.
Pubmed: 15882454
|